← Leaderboards
Anna Broder
Albert Einstein College Of Medicine, Inc
$832,074
Attributed
$832,074
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $177.7K · FY2017–21$200K$150K$100K$50K$0
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$832,074 · 1
By mechanism
K23$832,074 · 1
Top collaborators
No co-investigators on record.
Most similar at Albert Einstein College Of Medicine, Inc
Same institution · by research overlap
- Yinghao Wu$2,960,077
Others in their field
Other Emerging Leaders on “Graft Failure”
- Geoffrey Roger Hill · Fred Hutchinson Cancer Center$8,351,670
- Jean Kwun · Duke University$6,130,833
- Marlena Habal · Columbia University Health Sciences$5,428,816
- Colleen Bauza · Jaeb Center For Health Research, Inc.$4,053,339
- Derek K Ng · Johns Hopkins University$3,735,469
- Benjamin G Vincent · Univ Of North Carolina Chapel Hill$3,644,761
Research focus
Graft FailureAccountingAntiphospholipid AntibodiesBiometryCareer DevelopmentAreaCessation Of LifeAutoimmune DiseasesClinical ResearchCollegeComparative EffectivenessCost EffectiveData AnalysesCaringDatabasesData CollectionClinical InvestigationDesignDiagnosisEnd Stage Renal FailureEnrollmentEventFlareGuidelines
Grant awards (6)
The impact of hydroxychloroquine use on thrombosis and mortality in lupus-related end stage renal disease$121,434
K23 · FY2021 · AR · contact PI
The impact of hydroxychloroquine use on thrombosis and mortality in lupus-related end stage renal disease$177,660
K23 · FY2020 · AR · contact PI
The impact of hydroxychloroquine use on thrombosis and mortality in lupus-related end stage renal disease$177,660
K23 · FY2019 · AR · contact PI
The impact of hydroxychloroquine use on thrombosis and mortality in lupus-related end stage renal disease$105,099
K23 · FY2018 · AR · contact PI
The impact of hydroxychloroquine use on thrombosis and mortality in lupus-related end stage renal disease$72,561
K23 · FY2018 · AR · contact PI
The impact of hydroxychloroquine use on thrombosis and mortality in lupus-related end stage renal disease$177,660
K23 · FY2017 · AR · contact PI